3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Prostatic Neoplasms
21
Uterine Cervical Neoplasms
16
Esophageal Neoplasms
3
Endometrial Neoplasms
3
Breast Neoplasms
3
Vaginal Neoplasms
2
Rhabdomyosarcoma
2
Parkinson Disease 4, Autosomal Dominant Lewy Body
2
Neoplasms
2
Melanoma
2
Uveal Melanoma
1
Uterine Neoplasms
1
Sarcoma
1
Retinoblastoma
1
Recurrent Head and Neck Carcinoma
1
Radiation Injuries
1
Prostatic Diseases
1
Neuroectodermal Tumors, Primitive, Peripheral
1
Metastatic Malignant Female Reproductive System Neoplasm
1
Lung Neoplasms
1
Locally Advanced Cervical Adenocarcinoma
1
Gynecologic Cancer
1
Esophageal Squamous Cell Carcinoma
1
Endometrial Clear Cell Adenocarcinoma
1
Desmoplastic Small Round Cell Tumor
1
Cervical Adenocarcinoma
1
Carcinosarcoma
1
Carcinoma, Renal Cell
1
Carcinoma, Hepatocellular
1
Carcinoma, Ductal, Breast
1
Interventions
Temozolomide
19
Magnetic Resonance Spectroscopy
15
Radiotherapy
14
Specimen Handling
13
Radiation
9
Biopsy
5
pembrolizumab
4
Radiotherapy, Intensity-Modulated
4
Nivolumab
4
Bevacizumab
4
vorasidenib
3
trametinib
3
Surgical Procedures, Operative
3
Spinal Puncture
3
tovorafenib
2
dabrafenib
2
Restraint, Physical
2
Leukapheresis
2
Ipilimumab
2
Genetic Therapy
2
Fluorodeoxyglucose F18
2
Eflornithine
2
Craniotomy
2
Carboplatin
2
14-methyl-20-oxa-5,7,14,26-tetraazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa-1(25),2(26),3,5,8(27),9,11,16,21,23-decaene
2
vocimagene amiretrorepvec
1
veliparib
1
trastuzumab deruxtecan
1
tozuleristide
1
tocilizumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Astrocytoma
×
Brachytherapy
×
1 year
×
Clear all
No trials found.